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Soft tissue sarcoma is one of the commonest orthopaedic related malignancy. 
Approximately 80% of sarcoma arises from soft tissue and 20 % from bone⁸ ³. However, from the 
general point of view, soft tissue sarcoma is one of the rarest malignancies with incidence reported 
was less than 1%. Its classification is based on the direction of the differentiation of the soft tissue 
either collagen (fibrous tissue), fat or cartilage for instance.  
 
Several demographic factors and a few other possible prognostic factors have been 
demonstrated previously that may influence the patients’ survival. This study involved 128 patients 
for 10 years duration (1st January 2001- 31st January 2010) from one of the tertiary center for 
orthopaedic oncology in the country. Besides demographic studies, the prognostic clinical 
characteristics were assessed for differences in overall survival by using Kaplan Meier method as 
well as Cox proportional hazard regression.  
From this study, it was found the overall median survival time was 10 years with 5- year 
overall survival of 58%. No demographic results were statistically significant in affecting the 
overall survival (age, sex, sites of tumor, and subtypes, p-value >0.05). Treatments of soft tissue 
sarcoma for example limb salvage or amputation surgery, pre- and post- operative chemotherapy 
and radiotherapy, as well as outcome of the tumor which was second malignancy were all not 
statistically significant as well (p- value >0.05).  
 
Pulmonary and distant (non-pulmonary) metastasis, and local recurrence were the 
prognostic factors that significantly affect the overall survival (p <0.001). Nevertheless, after a 
multivariate analysis, only pulmonary (CI:3.08, p <0.001) and distant (non-pulmonary) (CI:2.30, 
p <0.004) metastasis were significantly associated with survival. 
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2.1 ABSTRAK 
 
Sarcoma tisu lembut merupakan antara kanser paling kerap dikesan dalam bidang 
ortopedik onkologi. Ia terdiri daripada 80% dan selebihnya 20% daripada kanser tulang. Secara 
umumnya, kanser tisu lembut sebenarnya merupakan antara satu daripada kanser yang sukar 
didapati berbanding dengan jenis lain. Kanser ini boleh dikelaskan mengikut jenis tisu asal ia 
bermutasi seperti kolagen, lemak mahupun tulang rawan misalnya.  
 
Beberapa data demografik serta faktor yang boleh memberi impak kepada nilai hidup 
pesakit kanser telah dikaji sebelum ini. Kajian kali ini melibatkan 128 pesakit dalam tempoh 10 
tahun (1 Januari 2001 hingga 31 Disember 2010) satu daripada pusat rawatan tertiari utama 
ortopedik onkologi negara. Selain daripada faktor demografik, pelbagai faktor lain yang mungkin 
memberikan kesan turut dinilai di mana beberapa ujian seperti “Kaplan Meier” serta “Cox 
proportional hazard regression”.  
 
Hasil daripada kajian ini menunjukkan tempoh “median survival time” selama 10 tahun 
dengan kadar “5- year survival” sebanyak 58%. Turut didapati tiada aspek demografik (umur, 
jantina, sub- jenis tumor, lokasi) adalah tidak signifikan dengan nilai p > 0.05. Aspek rawatan 
sarkoma tisu lembut juga turut dinilai dan didapati rawatan pembedahan, kemoterapi, radioterapi, 
serta komplikasi kanser seperti barah seterusnya turut tidak signifikan dengan nilai p > 0.05.  
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Namun begitu, aspek komplikasi kanser yang lain iaitu kanser yang berulang, kanser yg 
merebak ke paru-paru serta organ lain didapati memberi kesan kepada kehidupan pesakit, 
dibuktikan dengan nilai p <0.001. Tetapi, apabila ujian “Cox proportional hazard regression” 
dijalankan, hanya kanser yang merebak ke paru- paru (CI:3.08, p <0.001)  serta organ lain (CI:2.30, 
p <0.004)  yang memberikan kesan negatif kepada nilai hidup pesakit. 
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2.2 ABSTRACT 
 
Soft tissue sarcoma is one of the commonest orthopaedic related malignancy. 
Approximately 80% of sarcoma arises from soft tissue and 20 % from bone⁸ ³. However, from the 
general point of view, soft tissue sarcoma is one of the rarest malignancies with incidence reported 
was less than 1%. Its classification is based on the direction of the differentiation of the soft tissue 
either collagen (fibrous tissue), fat or cartilage for instance.  
 
Several demographic factors and a few other possible prognostic factors have been 
demonstrated previously that may influence the patients’ survival. This study involved 128 patients 
for 10 years duration (1st January 2001- 31st January 2010) from one of the tertiary center for 
orthopaedic oncology in the country. Besides demographic studies, the prognostic clinical 
characteristics were assessed for differences in overall survival by using Kaplan Meier method as 
well as Cox proportional hazard regression.  
 
From this study, it was found the overall median survival time was 10 years with 5- year 
overall survival of 58%. No demographic results were statistically significant in affecting the 
overall survival (age, sex, sites of tumor, and subtypes, p-value >0.05). Treatments of soft tissue 
sarcoma for example limb salvage or amputation surgery, pre- and post- operative chemotherapy 
and radiotherapy, as well as outcome of the tumor which was second malignancy were all not 
statistically significant as well (p- value >0.05).  
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Pulmonary and distant (non-pulmonary) metastasis, and local recurrence were the 
prognostic factors that significantly affect the overall survival (p <0.001). Nevertheless, after a 
multivariate analysis, only pulmonary (CI:3.08, p <0.001) and distant (non-pulmonary) (CI:2.30, 
p <0.004) metastasis were significantly associated with survival. 
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3.0 INTRODUCTION 
 
 
3.1 BACKGROUND AND STUDY LITERATURE 
 
 
 
Soft tissue sarcoma is a rare malignancy, with only less than 1% from all adult 
malignancies¹. Nonetheless, it comprises 60-70% of the most common orthopaedic related soft 
tissue malignancy before bone related tumours ². It is classified depending on the direction of the 
differentiation of the soft tissue either collagen (fibrous tissue), fat or cartilage for instance. 
 
Based from the Malaysia Cancer Registry in year 2007, extremities soft tissue sarcoma is 
the least common malignancy and included in the “others” category due to its small fraction ³.  
Nevertheless, the treatment for soft tissue sarcoma is not only unique but it caters to different 
histology, grade and type of the sarcoma. Over the years the treatment evolves from limb 
amputation to limb salvage surgery with adjuvant treatments such as radiotherapy and 
chemotherapy given either pre- operative or post- operatively.  
 
 
 
 
10 
 
There have been many studies produced that show effectiveness and the appropriateness 
of the treatment or therapy recommended to help prolonged patients’ survival. However, in our 
local setting we had yet to see sufficient data on the prevalence, incidence and the prognosis in 
relation to the current treatment. Therefore, this study is intended to analyze the survival of patients 
referred to ‘Hospital Universiti Sains Malaysia’ (HUSM) for management of the extremities soft 
tissue sarcoma. 
 
3.2 PROBLEM STATEMENT 
 
 
 
Soft tissue sarcoma is not one of the commonest malignancy, with incidence less than 5/100 
000 population³˒⁴ . Despite that, its management involves multi- disciplines which is mandatory 
(surgeons, radiologists, pathologists, oncologists)⁵ . This is to ensure the survival and to improve 
the quality of life of the patients. 
 
A malignant soft tissue swelling should be suspected when there is a presence of deep 
swelling with its size more than 5cm in diameter⁶ . After adequate clinical assessment, imaging 
like radiographs and MRI are needed before proceeding with tissue diagnosis via biopsy⁷ ˒⁸ . 
Once a tissue diagnosis of soft tissue sarcoma is obtained, definite management will be decided. 
Before patients undergo surgery, it has to be decided which type of surgery would provide the best 
function to the patients, in which options are either wide resection and reconstruction, limb 
amputation or even joint disarticulation. Adjunct therapies post operatively may need to be given 
depending on the formal histopathological diagnosis as well as per discussion with the oncologist. 
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There are a few options available such as brachytherapy, post- operative radiotherapy or 
chemotherapy. There has been conflict with post- operative chemotherapy, despite it may assist in 
prolonging disease- free survival, there was no proven benefit seen in improving overall survival. 
In a certain condition such as highly malignant, large or borderline resectable tumors, a pre- 
operative radiotherapy or chemotherapy might be considered.  
 
In keeping with the current management for the soft tissue sarcoma, a lot of studies has 
shown improvement in survival of the patients. With promising numbers internationally, I would 
like to see how the trend like in Malaysia is. To date there is yet a study to discuss on the survival 
and outcome of the soft tissue sarcoma. Hopefully with this study it would help to visualize the 
response of the current treatment in Malaysia’s population. We can also observe the prevalence 
and incidence of this disease in local setting. Besides, with HUSM as one of the oncology center, 
this will help in establishment of the database of the soft tissue sarcoma when subsequent data 
needs to be collected.  
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4.0 LITERATURE REVIEW 
 
4.1 EPIDEMIOLOGY 
 
Soft tissue sarcoma (STS) is one of the rarest mesenchymal malignancies. They are 
heterogenous with more than 50 types currently reported⁵ ¹. A multidisciplinary approach is 
mandatory to minimize recurrence, to maximize survival and preserve functionality and quality of 
life ⁴ ³. Approximately 80% of sarcoma arises from soft tissue and 20 % from bone²⁴ . It accounts 
for 1% of adult tumor and 15% of pediatrics age group tumor ²⁵ .  
 
From the European study, the incidence of soft tissue sarcoma reported was less than 5/ 
100 000/ year⁹ . In the United States, around 8700 new soft tissue sarcomas were diagnosed yearly 
while 1500 cases were reported annually in the UK²⁶ . On the other hand, in Asia pacific region, 
18000 new cases of sarcoma of bone and soft tissue were reported which accounted around 14400 
soft tissue sarcoma cases expected each year²⁴ . From Malaysia National Cancer Registry 2007- 
2011, out of 103 507 cases of malignancy reported, only 434 of them (0.004%) was of soft tissue 
sarcoma⁵ ⁵ .  
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4.1.1 AGE AND GENDER PREDISPOSITION 
 
In soft tissue sarcoma, there is no obvious gender predisposition. There is however slight 
male predominance in liposarcoma³°˒⁵ °.  
 
In adult soft tissue sarcoma, it is more prominent with increasing age with median age 
onset at 56-58 years old³°˒³⁵ . Based on World Health Organization (WHO), the onset of the 
disease is more common in the 6th decade of life¹⁴ ˒²⁵ . On a contrary, myxoid type liposarcoma 
has an earlier age of onset with peak incidence between 4th to 5th decade of life. Synovial sarcoma 
also shows earlier age of onset, typically below 40 years of age. Otherwise other types of 
liposarcoma, and other sarcomas for instance pleomorphic sarcomas, fibrosarcoma and 
leiomyosarcoma, majority of the occurrence are within the mentioned age groups. 
 
4.1.2 SITE 
 
Soft tissue sarcoma can arise from any sites of body, however the highest incidence were 
noted from lower extremities. Lower limb is the most involved site with 46%, followed by trunk 
19%, upper limb 13%, retroperitoneum 12%, head and neck 9% and other regions 1%⁴ ⁴ . Thigh 
region is the most affected area of the lower limb which usually located in deep soft tissue⁶ ³. 
Some of the soft tissue sarcomas are anatomical dependent; pleomorphic sarcoma and liposarcoma 
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are commonly found in extremities while leiomyosarcoma and also liposarcoma are also 
commonly found in retroperitoneum and intra- abdominal cavity⁴ ⁴ . 
 
Pleomorphic sarcoma being the most common soft tissue sarcoma has more affinity to deep 
seated skeletal muscles in the extremities. It rarely occurs in retroperitoneum or intra-abdominally. 
This is not so different from fibrosarcoma, as it also arises from fascia and aponeurosis of deep 
structures, similarly it takes after deep locations. Likewise, for synovial sarcoma, it 
correspondingly occurs in deep tissues, as it originates from area at close proximity with joints⁴ ⁴ . 
 
As for liposarcoma, as mentioned earlier, is commonly found in the lower extremities, with 
pelvis and thigh region being the most predominant sites. These findings support with what had 
been reported worldwide²⁵ ˒⁵ ³˒⁵ ¹. In most literature, the retroperitoneum and lower extremities 
are reported to have high incidence of large liposarcoma. 
 
4.1.3 TUMOR SIZE 
 
Soft tissue sarcomas are often detected late, with common presentation of large mass that 
has been growing for lengthy period, and painless. Sometimes patients present with compressive 
effect due to the large mass occupying the compartment and impinges on the nearby structures. 
Especially when the mass originates from pelvic or intra- abdominal cavity, the tumor grows to a 
very significant size without causing any significant signs and symptoms. Similar symptoms and 
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trend can also be seen when the mass emerges from deeper soft tissue structures, it precludes 
positive finding during palpation during early part of the disease.  
 
4.2 SUBTYPES OF SOFT TISSUE SARCOMA 
 
The soft tissue sarcomas are classified from its histological features. They are distinguished 
from their cellular type, and aided by other histogenetic studies to obtain the accurate diagnosis 
such as histochemistry, immunohistochemistry, and electron microscopy. The identification is 
more challenging in malignant soft tissue due to lack of cell differentiation. Another way of 
classifying is by grading the histology into benign, low grade or high grade malignancy. The 
diagnosis will be further supported by other modalities such as clinical behavior, radio- imaging, 
and many more. 
 
Histogenesis Benign Malignant 
Fibrous  Fibromatosis  Fibrosarcoma  
Fibrohistiocytic  Benign fibrous histiocytoma Pleomorphic sarcoma 
Adipose  Lipoma  Liposarcoma  
Smooth muscle Leiomyoma  Leiomyosarcoma  
Vascular  Hemangioma  Angiosarcoma 
Striated muscle Rhabdomyoma  Rhabdomyosarcoma  
Synovial  Synovioma  Synovial sarcoma 
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Nervous  Schwannoma 
Neurofibromatosis 
MPNST 
PNET 
Osseous   Extraskeletal Ewing sarcoma 
Extraskeletal osteosarcoma 
Cartilaginous   Extraskeletal chondrosarcoma 
Lymphatics  Lymphangioma  Lymphangiosarcoma 
Malignant hemangiopericytoma 
Uncertain   Alveolar sarcoma 
Epithelioid sarcoma 
 
Table 1: Soft tissue tumor classification 
 
4.2.1 PLEOMORPHIC SARCOMA 
 
Pleomorphic sarcoma is the most common tumor in adults. As mentioned earlier, it is found 
commonly between 5th to 6th decade of life, and commonly occurs in lower extremities. It has an 
affinity to deep skeletal muscle. This tumor usually consists of mucoid lobules with high content 
myxoid ground substance and 5% would associates with haemorrhagic content. Therefore, often 
false diagnosis of hematoma was made instead due to this presentation. There are many variants 
depending on the predominant cell type such as fibroxanthoma, malignant fibroxanthoma or 
inflammatory fibrous histiocytoma. Histologically they consist of fibroblasts, histiocyte- like cells 
and primitive mesenchymal cells arranged in storiform manner. Some also has atypical and bizarre 
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giant cells with abnormal mitotic figure, which can be less commonly seen. Some tumor cells 
observed had rich myxoid matrix and usually indicates a more favourable prognosis than other 
subtypes. 
  
4.2.2 LIPOSARCOMA 
 
This type of sarcoma is the second most common after pleomorphic sarcoma. It also largely 
affects lower extremities with estimated 40% of the incidence followed by retroperitoneum. The 
same age group also affected by this type of sarcoma. The tumor is typically well circumscribed 
and multilobulated. 
.  
Its histological grade correlates well with the malignant potential. Well differentiated type 
provides the best prognosis, and consists of mature fat lobules, very few lipoblasts with 
fibrocollagenous tissues. The other type is myxoid, which comprises of mucinoid surface and 
round cell. It is the most common histological type in liposarcoma. The high grade liposarcomas 
are of pleomorphic and dedifferentiated type. They are associated with extensive haemorrhage and 
necrosis. The dedifferentiated type generally transforms from a multiple recurrence of well- 
differentiated type. Pleomorphic liposarcoma on the other hand, contains multivacuoles, lipoblasts 
as well as atypical stromal cells, with abnormal mitotic figures. These features are characteristic 
for the other high grade sarcomas as well, but presence of lipoblasts differentiates liposarcoma 
from the other subtypes. 
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4.2.3 FIBROSARCOMA 
 
This type of soft tissue sarcoma originates from the fascial and aponeurosis of deep soft 
tissue. It had a wide range of age group affected, from 30 till 80 years of age. This tumor is made 
up of fibroblasts, and they produce collagen fibers which in turn appear as bifringent wavy fibres. 
This feature is quite common in differentiated fibrosarcoma. These fibers are uniformly arranged 
spindle cells with intersecting fascicles which form herringbone pattern. They have minimal 
atypical cells and mitotic figures, thus it is challenging to distinguish between low grade 
fibrosarcoma with fibromatosis. On a contrary with poorly differentiated fibrosarcoma, it shows 
minimal fascicular arrangement and associated with more nuclear atypia, pleomorphism with high 
mitotic rate⁴ ⁴ . Because of these features, the diagnosis of fibrosarcoma can overlap with 
pleomorphic sarcoma. 
  
4.2.4 SYNOVIAL SARCOMA  
 
Despite being named synovial sarcoma, it is a misnomer as it occurs from region near the 
joint and not from within the joint itself. It usually affects younger age group around 30- 40 years 
old with male predominance. Synovial sarcoma is a high grade tumor with common incidence of 
pulmonary metastasis as well as regional lymph nodes metastasis. Most of the patients have poor 
prognosis of 50% in 5 years and as low as 25% in 10 years of overall survival.⁴ ⁴  
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The tumor is characterized by mineralization or calcification that can be identified from 
radio- imaging modalities. Rarely it has contiguity with synovium- line space. It is also presents 
with ill- defined mass with infiltration and gel- like consistency. Histopathologically there is 
biphasic or even monophasic cells with evidence of spindle and epithelial cells and further 
confirmed with multiple immunohistochemistry staining. The neoplasm also contains dense 
stromal hyalinization with focal calcification. The presence of calcification actually signifies a 
more favourable prognosis than its other subtypes⁴ ⁴ . 
 
4.2.5 LEIOMYOSARCOMA 
 
This is the sarcoma resulted from mutation from involuntary smooth muscle. It comprises 
of less than 7% of all soft tissue sarcoma of the extremity. It is more commonly affected the uterus 
and abdominal cavity. Incidence is found higher in the middle age group especially at 5th to 7th 
decade of life. Patients usually present with painful mass when it is deep seated. 
Histopathologically the tumor consists of spindle cells with abundant, fibrillary, ‘cigar- shaped’ 
and atypical nuclei. Secondary changes like focal haemorrhage can also be seen. Other areas also 
show fibrocollagenous adipose, muscle and tendinous tissue with focal areas of infiltration by the 
malignant tumor cells. Special staining will aid in confirming this type of sarcoma⁴ ⁴ . 
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4.2.6 RHABDOMYOSARCOMA 
 
This type of soft tissue sarcoma is less common as well. It originates from striated or 
skeletal muscle. Rhabdomyosarcoma is more common among paediatric age group than in adults. 
It is a highly malignant tumor that often results with poor prognosis in survival. This tumor occurs 
mainly at head and neck as well as genitourinary region. Incidence of extremity 
rhabdomyosarcoma is less than a third. Advancing age, large tumor size more than 5cm and 
location at the extremity are associated with worse prognosis and survival. 
 
There are a few types of rhabdomyosarcoma which are classified according to the 
predominant cells histopathologically. There are alveolar, pleomorphic, embryonal and anaplastic 
subtype. The alveolar subtype is highly predominant in the extremities. Microscopically 
rhabdomyoblasts and smooth muscles can be observed. Small round cells with hyperchromatic 
nuclei or even polygonal-shaped tumor cells with abundant eosinophilic cytoplasm and contained 
diagnostic cross striations are observed as well⁴ ⁴ . 
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4.3 STAGING 
 
4.3.1 LOCAL STAGING 
 
4.3.1.1  PLAIN FILM RADIOGRAPHY 
 
The role of plain radiograph in diagnosing soft tissue tumor is limited as compared to 
primary bone tumor. The well recognized drawback is lack of contrast resolution but this limitation 
should not be underestimated as it can still provide information on presence of matrix calcification, 
periosteal reaction and cortical destruction in soft tissue tumors. Furthermore, it is an easy, cheap 
and universally available tool ¹⁶ . 
 
4.3.1.2  CT SCAN 
 
CT scan has a little value in diagnosing primary soft tissue tumors as compared to bone tumors.  
 
4.3.1.3  MRI 
 
Magnetic resonance imaging has become the preferred modalities for primary soft tissue 
tumor evaluation as it provides superior soft tissue contrast resolution. Besides, it also provides 
true multiplanar images in axial, sagittal and coronal and devoid of artifacts which commonly 
appears in CT scan¹³˒⁵⁸. In addition, it can produce accurate diagnosis by delineating the soft tissue 
extent of the tumor⁷¹. 
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The intensity of signal varies from low (black) to high (white), depending on chemical 
composition of the soft tissues and the modalities of execution. T1 and T2 weighted image has a 
different signal intensity depending on the used times. Intravenous administration of gadolinum 
enhances hypervacular lesion and results in high signal intensity in T1 weighted images. STIR 
(Short T1 inversion recovery) supresses fat signal so gadolinum enhanced signal intensity are 
contrasted against black bone marrow or soft tissue fat. 
 
Different subtypes of soft tissue sarcoma manifests differently in MRI. In malignant fibrous 
lesions like pleomorphic sarcoma and fibrosarcoma, they show low signal on T1 and high signal 
on T2- weighted images. The subtypes of liposarcoma manifest differently in MR images. Few 
studies have been done to evaluate the different subtypes of liposarcoma in MRI. Well 
differentiated type has the appearance of high SI (signal intensity) lesion on T1 weighted image 
corresponding to fat with fine septae within it, and faint enhancement of lesion post gadolinum 
suggestive of little vascularity. As for myxoid type, T1 weighted image shows homogenous mass 
isointense with muscle and homogenous high signal intensity with linear septae in T2 weighted 
images. Post contrast usually shows heterogenous non-enhancing areas which corresponds with 
accumulated mucinous material with no capillary network. Pleomorphic and dedifferentiated 
liposarcoma, as well as other sarcoma for instance synovial sarcoma are aggressive and high grade. 
Haemorrhage and necrosis are usually present with high degree of cellular pleomorphism. On T1 
and T2 weighted image shows heterogenous mass containing low and high SI, indicates area of 
haemorrhage and necrosis with marked heterogenous enhancement post gadolinum which shows 
rich vascularity of this lesion ³˒²¹˒¹⁷ . 
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In conclusion, MR images play a vital role in diagnosis soft tissue tumor. However, the 
baseline imaging should still start with plain radiography and proceed with other imaging 
algorithms if needed. Biopsy is mandatory if malignancy is suspected as histology remains the 
gold standard for diagnosis ¹⁶ . 
 
 
4.3.1.4  COMPARING CT AND MRI AS LOCAL STAGING 
 
It has been well established that the MR imaging was more superior to CT scan. MRI can 
depict tumor boundaries and delineate interface between tumor and surrounding soft tissue, 
generally fat and muscle⁵ . MRI also demonstrates the anatomical relationship with neurovascular 
structures better as compared to CT. This is important as a part for pre- operative planning. 
Besides, the extent of involvement of bone marrow abnormality, if present, can be visualize 
clearly¹.  
 
Furthermore, the advantage of multiplanar images (coronal, sagittal and axial) from MRI 
adds on the superiority in visualizing the tumor from CT scan. It provides a clearer 3- dimensional 
image as compared to CT.  
 
However, CT is superior to MRI in showing mineralized tissue such as bone and calcium 
deposition¹⁶ . Sundaram M and colleagues, 1990 concludes that even though the rim of sclerotic 
bone is not seen in MRI, it can be pictured well in CT. However, it adds to no additional 
information to what that already available in plain x- rays⁶ ⁸ .  
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Panicek et al in 1999 concludes that CT and MR imaging are equally accurate in local 
staging of primary soft tissue and bone tumors⁵ ⁷ . 
 
In general, MR is superior to CT in studying the soft tissues, bone marrow and spine, while 
CT scan is better to study calcified tissues as well as the best imaging modalities for pulmonary 
metastasis. 
 
 
4.3.2 DISTANT STAGING 
 
4.3.2.1  CT SCAN 
 
Soft tissue sarcomas spread via hematogenously, particularly to the lung. Nicholas et al, 
2005 reported high grade soft tissue sarcoma such as pleomorphic sarcoma, fibrosarcoma, synovial 
sarcoma, pleomorphic and dedifferentiated type of liposarcoma has a high tendency for pulmonary 
metastasis. Nevertheless, there are other subtype such as myxoid subtype which favors extra 
pulmonary metastasis and synovial sarcoma which also commonly has lymphatic spread⁵². 
Michelle AG et al, stated high number of pulmonary metastasis in high grade subtypes with tumor 
size more than 5cm but statistically not significant²⁷.  
 
CT is the best modality to detect pulmonary nodules. It has the accuracy of 99.6% in 
detecting pulmonary spread and its sensitivity is greater than plain radiography and traditional 
tomography. Therefore, CT should be done as initial evaluation for patient suspected to have 
